Microbiome therapies have the potential to revolutionise our approach medicine, but until now, a lack of standardisation and regulation has hampered clinical development. Here, Chrysi Sergaki Jack Hassall from National Institute for Biological Standards Control discuss how they are developing reference reagents standardise analysis microbiome samples, research is now moving towards development ...
